Stay updated on Talazoparib in DNA Repair Defects Clinical Trial

Sign up to get notified when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talazoparib in DNA Repair Defects Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the clinical trial involving talazoparib in men with DNA repair defects and metastatic castration-resistant prostate cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:32:25.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to provide a detailed description of eligibility criteria, including examples such as a person's general health condition or prior treatments. This change offers more specific information about the criteria researchers use to select participants for clinical studies.
    Difference
    30%
    Check dated 2024-05-22T20:54:08.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:53:12.000Z thumbnail image

Stay in the know with updates to Talazoparib in DNA Repair Defects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talazoparib in DNA Repair Defects Clinical Trial page.